Robert Eugene Watson - 25 Jul 2025 Form 4 Insider Report for CEL SCI CORP (CVM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 Jul 2025, 07:56:00 UTC
Prior SEC filing
10 May 2024
Next SEC filing
29 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Robert Watson

Key filing fact

Robert Eugene Watson filed Form 4 for CEL SCI CORP (CVM) on 29 Jul 2025.

Key facts

  • This page summarizes Robert Eugene Watson's Form 4 filing for CEL SCI CORP (CVM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 29 Jul 2025, 07:56.

Change

  • Previous filing in this sequence was filed on 10 May 2024.
  • Current net transaction value: +$19,995.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001511858 Primary reporting owner

Watson Robert Eugene

Relationship
Director
Address
245 N. HIGHLAND AVE NE, SUITE 230-296, ATLANTA
Signature
Robert Watson
Signature date
29 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVM transaction

Common Stock

Purchase

Transaction value
$19,995
Shares
+2,919
Change %
+359%
Price
$6.85
Shares after
3,733
Date
25 Jul 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On July 25, 2025, Mr. Watson purchased 2,919 shares of restricted stock directly from the Company at the closing price on July 24, 2025, the most recent closing price available.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .